These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 4849880)

  • 1. [Testing of some N-lost-compounds by screening test for cytostatic activity (author's transl)].
    Keitel R; Pöge AW
    Arch Geschwulstforsch; 1974; 43(2):168-71. PubMed ID: 4849880
    [No Abstract]   [Full Text] [Related]  

  • 2. [Peptichemio--a new anti-blastic drug].
    Prusek W
    Postepy Hig Med Dosw; 1977; 31(6):833-54. PubMed ID: 604985
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cytostatic effect of vinylogous nitrogen mustard carbonamidium salts against transplanted tumors in an automatic preliminary test and a sequential test program].
    Gutsche W; Jungstand W; Wohlrabe K; Fischer GW; Lohs K
    Arch Geschwulstforsch; 1972; 39(2):121-7. PubMed ID: 5065117
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experiences and experimental studies with the cytostatic nitrogen mustard oxide in surgery].
    HENNE HF; MARGGRAF W
    Strahlentherapie; 1957; 15(Sonderbd. 37):281-3. PubMed ID: 13495779
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical experiences and experimental studies with the cytostatic nitrogen mustard oxide in gynecology].
    VASTERLING HW; HALFPAP E
    Strahlentherapie; 1957; 15(Sonderbd. 37):283-4. PubMed ID: 13495780
    [No Abstract]   [Full Text] [Related]  

  • 6. [Topical, intratumor and intravenous nitrogen mustard in the treatment of mycosis fungoides (author's transl)].
    Sánchez Yus E; Vanaclocha Sebastián F
    Med Clin (Barc); 1980 Sep; 75(5):199-202. PubMed ID: 6999251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Regression of a metastasizing disgerminoma by cytostatic drug therapy].
    THEISEN H
    Geburtshilfe Frauenheilkd; 1959 Mar; 19(3):252-6. PubMed ID: 13640218
    [No Abstract]   [Full Text] [Related]  

  • 8. [Relationships between chemical structure and biological activity in azomethines with nitrogen mustard groups on Ehrlich ascites tumor of the white mouse. 2. Azomethine without N-mustard groups as comparative substances and N-mustard azomethine with additional substitutions in the phenyl group].
    Schulze W; Gutsche W; Jungstand W
    Arzneimittelforschung; 1967 May; 17(5):605-7. PubMed ID: 5631589
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of phthalmustine, a new anticancer compound. I. Effect on Dalton's ascitic lymphoma in mice.
    Bhattacharya S; Ganguly C; Sanyal U; Das S
    Neoplasma; 1994; 41(1):35-8. PubMed ID: 8202193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preliminary report on the therapy of maligant tumors with a new N-lost-phosphamidester].
    BAUMANN E
    Medizinische; 1959 Apr; 4(14):659-62. PubMed ID: 13656279
    [No Abstract]   [Full Text] [Related]  

  • 11. Oxychlorine in cytostatic therapy of malignant blood diseases.
    CONSOLI G
    Minerva Med; 1955 May; 46(39):1386-8. PubMed ID: 14393802
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical experience report of a new cytostatic (endoxan); preliminary report].
    SAITMACHER H
    Strahlentherapie; 1958 Sep; 107(1):94-111. PubMed ID: 13603091
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cytostatic drugs in the treatment of malignant tumors; clinical experiences with mitomen].
    APEL G; KLAGES K
    Medizinische; 1957 Mar; (9):314-8. PubMed ID: 13430178
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cytostatic treatment of prostatic carcinoma. Evaluation study of estramustinphosphate].
    Anderes A; Arquint A; Camponovo F; Deppeler O; Doerig R; Heim H; Humbert-Droz P; Jung HP; Magaro L; Sasso M; Vischer C; Wanner J; Wegmann HJ; Ziegler E
    Schweiz Rundsch Med Prax; 1971 Sep; 60(38):1276-9. PubMed ID: 5094915
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prevention of propagation and metastasis of tumor cells after surgery or biopsy; cytostatic protection of surgery].
    STOGER R
    Arch Geschwulstforsch; 1953; 5(3):252-6. PubMed ID: 13105314
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of advanced metastasizing carcinoma of the prostate with estracyt (author's transl)].
    Rambausek M; Lutherer S; Terhorst B
    Urologe A; 1981 Jul; 20(4):223-7. PubMed ID: 7196632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlations between the chemical structure of Mannich bases with and without nitrogen mustard groups and their cytostatic effect on Ehrlich ascites carcinoma in albino mice].
    Werner W; Jungstand W; Gutsche W
    Arzneimittelforschung; 1970 Feb; 20(2):246-9. PubMed ID: 5467470
    [No Abstract]   [Full Text] [Related]  

  • 18. [Animal experimental examination of a phase III study on the effect of the combination therapy of bruneomycin, cytostasan and prednisone].
    Nowak C; Arnold W; Henneberger G; Tanneberger S
    Arch Geschwulstforsch; 1983; 53(1):37-44. PubMed ID: 6344835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of cytostatic drugs for glomerulonephritis in children].
    Iakubchik FM
    Vopr Okhr Materin Det; 1971 Dec; 16(12):12-6. PubMed ID: 5159157
    [No Abstract]   [Full Text] [Related]  

  • 20. [Nitrogen mustard as an antiphlogistic drug].
    SCHEUER-KARPIN R
    Z Arztl Fortbild (Jena); 1956 Dec; 50(23):978-83. PubMed ID: 13409933
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.